← Leaderboards
Debra Auguste
City College Of New York
$2,966,001
Attributed
$2,966,001
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2012–22$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,966,001 · 2
By mechanism
DP2$2,766,001 · 1
R56$200,000 · 1
Top collaborators
No co-investigators on record.
Most similar at City College Of New York
Same institution · by research overlap
- Maribel Vazquez$1,313,817
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisBiodistributionLiposomesReceptorIn VitroDensityEngineeringIn VivoMalignant NeoplasmsTumorLymphocyteBreast Cancer CellBaseCytokineAntibodiesCell SurfaceAromatase InhibitorsComplementCxc ChemokinesDesignChemokineChemical EngineeringClinical TrialsChemokine Receptor
Grant awards (4)
Peptide conjugated liposomes activate anti-tumor immunity$200,000
R56 · FY2022 · CA · contact PI
Personalized Therapeutics for Inhibiting Breast Cancer Metastasis$471,000
DP2 · FY2017 · CA · contact PI
Personalized therapeutics for inhibiting breast cancer metastasis$1,925,413
DP2 · FY2012 · CA · contact PI
Personalized Therapeutics for Inhibiting Breast Cancer Metastasis$369,588
DP2 · FY2012 · CA · contact PI